Underuse of statins in MASLD despite population-based associations with lower liver stiffness.

4 Nevertheless, our data demonstrate that there may be significant untapped preventive potential among individuals with MASLD: one-third did not use statins while meeting contemporary criteria for treatment, and another third did not use statins even though statin use could be considered according to contemporary 2025 ESC/EAS guidelines.

also in 13,097 other papers